WEBINAR

Friday, June 13, 2025 | 10am EDT (NA) / 3pm BST (UK) / 4pm CEST (EU-Central) 60 min


The design of synthetic peptide analogues offers potential to overcome several inherent limitations of natural peptides, including rapid degradation, poor permeability and adverse effects.

This webinar will discuss key absorption, distribution, metabolism and excretion (ADME) characteristics in peptide drug development, showcasing in-vitro data from representative examples across different peptide classes, including natural peptides, hormones, cyclic peptides, GLP-1 analogues and synthetic D-amino acid peptides.

Attendees will gain insights into the key ADME properties that influence novel peptide therapeutics, with a focus on:


Evaluation of peptide stability in biological matrices (plasma, liver, intestine, kidney) and resistance to proteases
Mechanisms of protease resistance and strategies for improving metabolic stability
Assessment of in-vitro permeability and factors affecting absorption


This webinar is ideal for professionals involved in peptide drug development, formulation scientists, pharmacokinetic experts and anyone interested in advancing the stability and performance of peptide-based therapeutics.

Register for this webinar to gain valuable insights into ADME properties across diverse peptide classes and discover strategies to enhance metabolic stability and drug-like performance.

Register Now


Speakers:
Subas Sakya.png
Haoqing Chen, Ph.D.
Lead of ADME
BioDuro

We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all